Sign in / Join Now
ETFs & Funds
Myriad Genetics: Is The Correction An Investing Opportunity $
Add a reply...
Latest StockTalks »
people get MYGN breaking news and analysis by email alert.
Get email alerts on MYGN »
Myriad Genetics, Inc.
Get latest price
From other sites
Myriad Genetics: Evidence Street Reviews EndoPredict Test
at Zacks.com (Jan 6, 2017)
The EndoPredict® Test Receives Positive Coverage Decisions From Multiple Blue Cross Blue Shield Affiliate Plans
at TheStreet (Jan 6, 2017)
EndoPredict® Reviewed By Blue Cross Blue Shield Association's Evidence Street
at TheStreet (Jan 5, 2017)
Myriad Genetics' Unit Releases Favorable Data on Vectra DA
at Zacks.com (Dec 28, 2016)
Myriad Genetics To Present At The 2017 JP Morgan Healthcare Conference
at TheStreet (Dec 28, 2016)